136 related articles for article (PubMed ID: 38361556)
1. Very Late Patent Foramen Ovale Occluder Device Structural Dysfunction and Thrombosis.
Abazid RM; Smettei O; Nari J; De S; Mathew A; Sridhar K; Lin-Rui Ray G; Tzemos N
JACC Case Rep; 2024 Feb; 29(3):102179. PubMed ID: 38361556
[TBL] [Abstract][Full Text] [Related]
2. [Safety and efficacy of left atrial appendage closure combined with patent foramen ovale closure for atrial fibrillation patients with patent foramen ovale].
Zhao ZH; Song X; Wang SH; Luo J; Wu YB; Zhu Q; Fang M; Huan Q; Zhang XG; Tian B; Gu W; Zhu LN; Hao SW; Ning ZP
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Mar; 50(3):257-262. PubMed ID: 35340144
[No Abstract] [Full Text] [Related]
3. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
Wiktor DM; Carroll JD
Circ Cardiovasc Interv; 2018 Mar; 11(3):e004152. PubMed ID: 29870380
[TBL] [Abstract][Full Text] [Related]
4. Intermediate and long-term results of transcatheter closure of patent foramen ovale using the amplatzer patent foramen ovale occluder: one case of pulmonary embolism irrespective of patent foramen ovale closure.
Yoon JH; Kim JS; Lee DH; Shim EJ; Lee SY; Min KS; Cho DJ; Lee HR
Korean Circ J; 2011 Jul; 41(7):356-62. PubMed ID: 21860636
[TBL] [Abstract][Full Text] [Related]
5. Experimental study of the bilateral asymmetric single-rivet occluder device for transcatheter patent foramen ovale closure with reserved interatrial septal puncture area.
Wei Y; Su Y; Cao S; He Z; Wang R; Qin X; Feng Y; Yang C; Jiang H
Front Cardiovasc Med; 2023; 10():1301412. PubMed ID: 38250032
[TBL] [Abstract][Full Text] [Related]
6. Late results after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism using the amplatzer PFO occluder without intraprocedural echocardiography: effect of device size.
Wahl A; Tai T; Praz F; Schwerzmann M; Seiler C; Nedeltchev K; Windecker S; Mattle HP; Meier B
JACC Cardiovasc Interv; 2009 Feb; 2(2):116-23. PubMed ID: 19463412
[TBL] [Abstract][Full Text] [Related]
7. Clinical Experience of Percutaneous Patent Foramen Ovale Closure Using the Amplatzer PFO Occluder in Japanese Patients to Prevent the Recurrence of Cryptogenic Stroke.
Takafuji H; Obunai K; Makihara Y; Kato N; Watanabe H
Intern Med; 2021 Nov; 60(21):3385-3390. PubMed ID: 34024855
[TBL] [Abstract][Full Text] [Related]
8. Late thrombosis of Gore Cardioform septal occluder device in a patient with history of patent foramen ovale closure.
Khalil MH; Haider M; Mehta S
Radiol Case Rep; 2024 Apr; 19(4):1386-1390. PubMed ID: 38268740
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke.
Saver JL; Carroll JD; Thaler DE; Smalling RW; MacDonald LA; Marks DS; Tirschwell DL;
N Engl J Med; 2017 Sep; 377(11):1022-1032. PubMed ID: 28902590
[TBL] [Abstract][Full Text] [Related]
10. Patent foramen ovale with complex anatomy: Comparison of two different devices (Amplatzer Septal Occluder device and Amplatzer PFO Occluder device 30/35).
Giordano M; Gaio G; Santoro G; Palladino MT; Sarubbi B; Golino P; Russo MG
Int J Cardiol; 2019 Mar; 279():47-50. PubMed ID: 30344060
[TBL] [Abstract][Full Text] [Related]
11. Post-Market Clinical Follow-Up With the Patent Foramen Ovale Closure Device IrisFIT (Lifetech) in Patients With Stroke, Transient Ischemic Attack, or Other Thromboembolic Events.
Sievert K; Yu J; Bertog S; Hornung M; von Bardeleben RS; Gafoor S; Reinartz M; Matic P; Hofmann I; Grunwald I; Schnelle N; Sievert H
Cardiovasc Revasc Med; 2021 Sep; 30():72-75. PubMed ID: 33097460
[TBL] [Abstract][Full Text] [Related]
12. Patent foramen ovale closure in the management of cryptogenic stroke: a review of current literature and guideline statements.
Elzanaty AM; Patel N; Sabbagh E; Eltahawy EA
Curr Med Res Opin; 2021 Mar; 37(3):377-384. PubMed ID: 33460329
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter closure of patent foramen ovale with the Spider patent foramen ovale occluder: a prospective, single-center trial.
Zhang CJ; Huang YG; Huang XS; Huang T; Huang WH; Shen JJ; Xun ZR
Chin Med J (Engl); 2010 Apr; 123(7):834-7. PubMed ID: 20497673
[TBL] [Abstract][Full Text] [Related]
14. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
15. Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 Trials.
Kent DM; Saver JL; Ruthazer R; Furlan AJ; Reisman M; Carroll JD; Smalling RW; Jüni P; Mattle HP; Meier B; Thaler DE
Stroke; 2020 Oct; 51(10):3119-3123. PubMed ID: 32921262
[TBL] [Abstract][Full Text] [Related]
16. Amplatzer PFO occluder device may prevent recurrent stroke in patients with patent foramen ovale and cryptogenic stroke: a meta-analysis of randomised trials.
Pandit A; Aryal MR; Pandit AA; Jalota L; Kantharajpur S; Hakim FA; Lee HR
Heart Lung Circ; 2014 Apr; 23(4):303-8. PubMed ID: 24495944
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of Cardi-O-fix occluder for percutaneous closure of a patent foramen ovale: A single-center prospective study.
Zhao E; Liu W; Zhang Y; Cheng G; Du Y; He L; Wang X; He X
Medicine (Baltimore); 2017 Apr; 96(14):e6572. PubMed ID: 28383438
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of a novel occluder device (Occlutech) for percutaneous transcatheter closure of patent foramen ovale (PFO).
Krizanic F; Sievert H; Pfeiffer D; Konorza T; Ferrari M; Figulla HR
Clin Res Cardiol; 2008 Dec; 97(12):872-7. PubMed ID: 18696022
[TBL] [Abstract][Full Text] [Related]
19. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
Aral M; Mullen M
Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379
[TBL] [Abstract][Full Text] [Related]
20. Long-term transesophageal echocardiography after patent foramen ovale closure by BioSTAR and Amplatzer patent foramen ovale occluders.
Suligoj NC; Rojko M; Suligoj B; Zorc M; Kar S; Noc M
Catheter Cardiovasc Interv; 2020 Feb; 95(3):349-354. PubMed ID: 31131978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]